Cardiac histones are substrates of histone deacetylase activity in hemorrhagic shock and resuscitation

被引:56
作者
Lin, T
Alam, HB
Chen, HZ
Britten-Webb, J
Rhee, P
Kirkpatrick, J
Koustova, E
机构
[1] Harvard Univ, Div Trauma Emergency Surg & Surg Crit Care, Massachusetts Gen Hosp, Sch Med, Boston, MA 02114 USA
[2] Washington Hosp Ctr, Washington, DC 20010 USA
[3] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA
关键词
D O I
10.1016/j.surg.2005.08.022
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. DIVA transcription is regulated, in Part, by acetylation of nuclear histomes that are, controlled by 2 groups of enzymes: histone deacetylases (HDAC) and histone acetyl transferases (HAT). Whether an imbalance in HDAC/HAT system plays a role in hemorrhage/resuscitation is unknown. The goals of this study were to determine whether hemorrhage results in deacetylation of cardiac histones and whether this can be corrected through the application of different resuscitation strategies or specific HDAC inhibitors. Methods. In the first experiment, rats (n = 6 per group) were subjected to volume-controlled hemorrhage and resuscitated with racemic lactated Ringer's solution, L-lactated Ringer's solution, 7.5 % hypertonic saline solution, ketone Ringer's solution, and pyruvate Ringer's solution. Control groups included no hemorrhage (sham) and hemorrhage with no resuscitation. In the second experiment (n = 5 Per group), 3 HDAC inhibitors (valproic acid, trichostatin A. and suberoylanilide hydroxamic acid) were added to saline solution resuscitation. Heart tissue was collected at the end of resuscitation. Isolated subcellular protein fractions were used in Western, blotting to analyze the patterns of total protein acetylation and histone acetylation specifically. HDAC and HAT activity was measured in tissue extracts. Results. Hemorrhage led to partial histone deacetylazion. Resuscitation resulted in protein hyper-acetylation in nuclear fractions only. A detailed analysis of histones (on 10 acelylation sites) revealed that ketone Ringers solution hyperacetylated histones H2B, H3, and H4. The addition of suberoylanilide hydroxamic acid hyperacetylated histones more effectively than other resuscitation strategies, presumably by direct inhibition of HDAC activity. Conclusion. Hemorrhage/resuscitation is associated with HDAC/HAT activity misbalance, and the acetylation status of cardiac histones is influenced by the choice of resuscitation strategy. Shock-induced changes can be reversed through the infusion, of pharmacologic HDAC inhibitor, even when it is administered after the insult for a limited period of time.
引用
收藏
页码:365 / 376
页数:12
相关论文
共 27 条
[1]   cDNA array analysis of gene expression following hemorrhagic shock and resuscitation in rats [J].
Alam, HB ;
Stegalkina, S ;
Rhee, P ;
Koustova, E .
RESUSCITATION, 2002, 54 (02) :195-206
[2]   Regulation of gene expression by transcription factor acetylation [J].
Bannister, AJ ;
Miska, EA .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2000, 57 (8-9) :1184-1192
[3]   Histone modifications in transcriptional regulation [J].
Berger, SL .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2002, 12 (02) :142-148
[4]   Emerging roles for chromatin remodeling in cancer biology [J].
Cairns, BR .
TRENDS IN CELL BIOLOGY, 2001, 11 (11) :S15-S21
[5]   Regulation of lifespan by histone deacetylase [J].
Chang, KT ;
Min, KT .
AGEING RESEARCH REVIEWS, 2002, 1 (03) :313-326
[6]   A therapeutic strategy uses histone deacetylase inhibitors to modulate the expression of genes involved in the pathogenesis of rheumatoid arthritis [J].
Chung, YL ;
Lee, MY ;
Wang, AJ ;
Yao, LF .
MOLECULAR THERAPY, 2003, 8 (05) :707-717
[7]   Histone deacetylases (HDACs): characterization of the classical HDAC family [J].
De Ruijter, AJM ;
Van Gennip, AH ;
Caron, HN ;
Kemp, S ;
Van Kuilenburg, ABP .
BIOCHEMICAL JOURNAL, 2003, 370 :737-749
[8]   Histone acetylation in chromatin structure and transcription [J].
Grunstein, M .
NATURE, 1997, 389 (6649) :349-352
[9]   Transcription: Gene control by targeted histone acetylation [J].
Imhof, A ;
Wolffe, AP .
CURRENT BIOLOGY, 1998, 8 (12) :R422-R424
[10]   Histone deacetylase inhibitors: from target to clinical trials [J].
Kelly, WK ;
O'Connor, OA ;
Marks, PA .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2002, 11 (12) :1695-1713